Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery (S0931)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01120249
First received: May 7, 2010
Last updated: October 4, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2021
  Estimated Primary Completion Date: October 2021 (Final data collection date for primary outcome measure)